Thank you, Dan, and good morning, everyone. Before I discuss our first quarter financial performance, I'd like to recap a few housekeeping items, which impacted our year-over-year comparability in the quarter. First, as noted in our earnings release, during the first quarter, we sold our investment in Mediant. DFIN received proceeds of $11.8 million from the sale, including $8.9 million of cash and common stock of the acquirer. The sale resulted in a pretax gain of $6.7 million, which is recorded within corporate on the investment and other income line of our income statement. Second, as discussed on last quarter's earnings call, we completed the disposition of our EdgarOnline software offering in the fourth quarter of 2022. For the full year 2023, the disposition negatively impacts the year-over-year total net sales comparison by approximately $5 million, with the vast majority of the impact affecting the first 3 quarters of this year. The impact on our gross profit and non-GAAP adjusted EBITDA comparisons is de minimis. For purposes of segment level year-over-year net sales change discussions, I will refer to the organic net sales change, which adjusts for the impacts of the EdgarOnline disposition as well as changes in foreign exchange rates. A reconciliation of reported to organic net sales change is included in our earnings release. Finally, certain technology expenses that were included in cost of sales in 2022 are recorded within SG&A in 2023. As a result, compared to the first quarter of 2022, there was a $2.6 million reduction to cost of sales and a corresponding $2.6 million increase in SG&A with no impact to the year-over-year comparability in non-GAAP adjusted EBITDA or consolidated net earnings. This change positively impacts year-over-year gross margin comparability by approximately 130 basis points and negatively impacted non-GAAP SG&A as a percentage of sales by approximately 130 basis points. We expect a similarly sized dollar comparability impact on cost of sales and SG&A for each of the 3 remaining quarters of 2023. Now turning to our first quarter results. As Dan noted, we delivered strong results in the quarter despite the prolonged downturn in the capital markets transactional environment that continues to negatively impact our transactionally-driven offerings. The volume of capital markets deal activity remained substantially below last year's levels as the market softness we experienced throughout 2022 continued into the first quarter of 2023. Given the weak demand environment for corporate transactions, consistent with our historical approach of aggressively managing our cost structure, we took additional cost reduction actions in the first quarter, while at the same time, continued to invest in initiatives that accelerate our transformation. Our first quarter operating results included approximately $5 million of incremental investments related to these initiatives with approximately $4 million in additional product and technology investments to accelerate the development of our software solutions and the remaining $1 million aimed toward the modernization of certain business processes in order to improve operating efficiencies. In total, these additional costs impacted our first quarter adjusted EBITDA margin by approximately 250 basis points. As mentioned previously, these incremental investments, which we expect to continue for the rest of 2023 as part of our investment plan, do not represent a permanent increase to our cost structure. We expect to realize the benefits of these initiatives beginning late this year. On a consolidated basis, total net sales for the first quarter of 2023 were $198.6 million, a decrease of $12.4 million or 5.9% on a reported basis and 4.4% on an organic basis from the first quarter of 2022. Given the very weak transactional environment, substantially all of the year-over-year net sales decline took place in the capital markets transactional business, which was down $10.4 million or 20.2% versus the first quarter of last year. First quarter non-GAAP gross margin was 54.5%, approximately 140 basis points higher than the first quarter of 2022, primarily driven by the impact of cost savings initiatives, price benefits and the impact of changes between cost of sales and SG&A that I just mentioned, partially offset by lower capital markets transactional activity. Adjusted non-GAAP SG&A expense in the quarter was $66.3 million, a $5.3 million increase from the first quarter of 2022. As a percentage of net sales, adjusted non-GAAP SG&A was 33.4%, an increase of approximately 450 basis points from the first quarter of 2022. The increase in adjusted non-GAAP SG&A is primarily driven by the impact of changes between cost of sales and SG&A, incremental, transformation-related investments and higher bad debt expense, partially offset by a reduction in selling expenses as a result of lower sales volume and the impact of cost control initiatives. Our first quarter adjusted EBITDA was $42.4 million, a decrease of $8.7 million or 17% from the first quarter of 2022. First quarter adjusted EBITDA margin was 21.3%, a decrease of approximately 290 basis points from the first quarter of 2022, primarily driven by lower capital markets transactional sales and incremental investments in support of our strategic transformation, partially offset by the impact of cost control initiatives, price uplifts and lower selling expenses as a result of lower sales volume. Turning now to our first quarter segment results. Net sales in our Capital Markets Software Solutions segment were $43.7 million, an increase of 2.3% on an organic basis from the first quarter of last year. The net sales growth in this segment was led by our recurring compliance product, ActiveDisclosure, which grew approximately 6% in the quarter, with recurring subscription revenue growth of approximately 5%. As Dan commented earlier, we are nearing the end of our client transition from AD3 to new AD, a process for which we expected and realized a temporarily elevated customer churn rate. combined with the impact of SPAC liquidations, normal customer churn and the ongoing weakness in IPO activity, we saw a modest decline in the number of customers on the platform during the quarter. The reduction customer count, which resulted in a slowdown in subscription revenue growth, was more than offset by price increases on conversions, new customer wins and increase in service revenue. We expect this lower ActiveDisclosure subscription revenue growth to continue in the second quarter and then improve in the second half of the year as we complete the platform transition by the end of the second quarter. Net sales of our virtual data room offering Venue were down $0.2 million or 0.9% compared to the first quarter of last year despite a steep decline in M&A volume. Similar to what we experienced throughout 2022, Venue performed better than the market trend of its primary use case M&A during the first quarter. With the global M&A market down nearly 30%, on a year-over-year basis in the first quarter, we continue to be encouraged by the resiliency of Venue sales. Adjusted EBITDA margin for the segment was 16.9%, a decrease of approximately 550 basis points from the first quarter of 2022, primarily due to an unfavorable sales mix, an increased allocation of overhead costs and incremental investments in technology development, partially offset by price uplifts from new AD and cost control initiatives. Net sales in our Capital Markets, Compliance & Communications Management segment were $94.1 million, a decrease of 8.4% on an organic basis from the first quarter of 2022, driven by lower capital markets transactional activity, partially offset by a modest year-over-year growth in compliance revenue as a result of event-driven compliance volume in the quarter and favorable timing shifts. In a continuation of the prolonged downturn in capital markets transactional environment, the demand for equity transactions remained very low in the first quarter. As the quarter progressed, turmoil throughout the financial sector further escalated market volatility. Combined with the impact of persistent macroeconomic headwinds, elevated interest rates and geopolitical uncertainty, first quarter capital markets transactional sales were lower, both on a sequential as well as a year-over-year basis. In particular, the IPO market remained very sluggish during the first quarter with only 8 priced IPOs over $100 million taking place on U.S. exchanges compared to over 50 priced IPOs in the first quarter of 2022. The M&A market, while more resilient than the IPO market slowed sequentially from the fourth quarter of 2022 and was down nearly 30% versus last year's first quarter. The decline in capital markets transactional revenue is partially offset by our capital markets compliance offering, which grew approximately 2% year-over-year driven largely by an event-driven compliance project and favorable timing shifts relative to last year's first quarter. As a reminder, Capital Markets Compliance sales are seasonal with first and second quarters generating the highest levels of sales during the year driven by the peak in 10-K and proxy filings during those periods. Additionally, while our Capital Markets compliance offering, which supports our corporate clients with their ongoing compliance need, is mostly recurring in nature, there is a moderate component of event-driven revenue from filings such as transactional 8-Ks and special proxies, which are nonrecurring and can fluctuate from period to period. Further, the recent trend of increased SPAC liquidations creates a headwind on the number of public companies and the associated demand for compliance services. Adjusted EBITDA margin for the segment was 28.6%, a decrease of approximately 100 basis points from the first quarter of 2022. The decrease in adjusted EBITDA margin was primarily due to lower transactional sales, partially offset by cost control initiatives of lower overhead costs and lower selling expenses as a result of lower sales volume. Net sales in our Investment Companies Software Solutions segment were $26.4 million an increase of 6.4% on an organic basis versus the first quarter of 2022, largely driven by growth in subscriptions. As we've highlighted in the past, Arc Suite net sales growth benefited from the adoption of ArcDigital, our total compliance management offering, which was introduced in 2021 in response to regulatory change. We saw a strong adoption of total compliance management throughout 2021 and into the first quarter of 2022, which impacted the year-over-year growth in the first quarter of 2023. with demand more normalized following the onetime adoption, we expect a more modest growth related to this offering going forward. Based on Dan's earlier comments, we are optimistic about the opportunities created by regulations such as tailored shareholder reports and believe Arc Suite is well positioned to capture additional demand from new regulations to further accelerate a recurring software revenue growth. Adjusted EBITDA margin for the segment was 31.1%, a decrease of approximately 560 basis points from the first quarter of 2022. The decrease in adjusted EBITDA margin was primarily due to higher product development and technology investments in support of growth opportunities such as tailored shareholder reports and increased overhead costs, partially offset by cost savings initiatives and favorable price impacts. Net sales in our Investment Companies Compliance & Communications Management segment were $34.4 million, a decrease of 8.5% from the first quarter of 2022, driven primarily by the exit of low-margin work, partially offset by higher service fees and price uplifts. Adjusted EBITDA margin for the segment was 27.3%, approximately 180 basis points higher than the first quarter of 2022. The increase in adjusted EBITDA margin was primarily due to a favorable sales mix, featuring more services and less print, the impact of cost savings initiatives and price uplifts partially offset by higher overhead costs. Non-GAAP unallocated corporate expenses were $9.5 million in the quarter, an increase of $1.1 million from the first quarter of 2022, primarily driven by an increase in expenses aimed at accelerating our transformation, partially offset by the impact of ongoing cost control initiatives. Free cash flow in the quarter was negative $62.1 million, flat to the first quarter of 2022 as the decline in adjusted EBITDA, unfavorable working capital changes and higher interest payments were offset by lower incentive-based and sales commission payments made in the first quarter of this year versus payments made in the first quarter of 2022 related to our 2021 performance. We ended the quarter with $234.8 million of total debt and $206 million of non-GAAP net debt, including $110.5 million drawn on our revolver. From a liquidity perspective, we had access to the remaining $189.5 million of our revolver as well as $28.8 million of cash on hand. As of March 31, 2023, our non-GAAP net leverage ratio was 1.0x. As a reminder, our cash flow is historically seasonal. We are user of cash in the first quarter, closer to breakeven in the second quarter and generate more than 100% of our free cash flow in the second half of the year. As our sales mix continues to evolve to proportionately more subscription-based sales, we expect the seasonality to continue to become less significant. Regarding capital deployment, we repurchased approximately 34,000 shares of common stock during the quarter for $1.3 million at an average price of $38.82 per share. As of March 31, 2023, and we had $123 million remaining on our $150 million stock repurchase authorization. Given the current high interest rate environment and our floating rate debt, we assigned a higher priority to debt management which resulted in lower share repurchases. Going forward, we will continue to take a balanced approach towards capital deployment. We continue to view organic investments to drive our transformation, share repurchases and net debt reduction each as key components of our capital deployment strategy and will remain disciplined in this area. As it relates to our outlook for the second quarter of 2023, while we expect the overall macroeconomic environment to remain challenging, we are encouraged with a modest pickup in the transactional activity so far in the second quarter. Through April, priced IPO showed slight improvement from the first quarter, large M&A transactions, while still below last year's level, improved sequentially as well. While we are encouraged by the pickup in activity to start the quarter, we remain cautious as the pace of transactional activity can change very quickly. In addition, consistent with our priorities for 2023, we will continue to execute our investment plan in the second quarter with additional operating expenses directed toward accelerating our transformation. We expect a similar level of incremental investment during the second quarter compared to the level from the first quarter. With that as the backdrop, we expect consolidated second quarter sales in the range of $220 million to $240 million and non-GAAP adjusted EBITDA margin in the mid-20% range. Compared to the second quarter last year, the midpoint of our revenue guidance, $230 million implies a year-over-year net sales decline of approximately 14%, primarily as a result of lower transactional activity. From a margin perspective, our guidance of mid-20% range, contemplates a lower level of transactional revenue compared to the second quarter of 2022 as well as the incremental investments, which I described earlier. We expect our second quarter non-GAAP adjusted EBITDA margin to be once again much stronger than historical quarters of like-sized total and transactional sales. Let me also provide a bit more color on our assumptions for Capital Markets, Compliance & Communications Management segment. At the midpoint of our sales range, we assume a modest increase in second quarter transactional sales compared to the level we reported in the first quarter this year, reflecting the higher level of activity we've experienced so far this quarter. As it relates to compliance based sales within the segment, in line with normal seasonality, we expect the second quarter to be the largest sales quarter of the year. We also expect second quarter compliance sales to decline modestly compared to a very strong second quarter of 2022. Second quarter 2023 compliance sales will be impacted by the combination of certain compliance volumes shifting from the second quarter into the first quarter as well as a decline in compliance revenue from SPACs which benefited the second quarter of 2022, and many of those entities have since liquidated. These declines are expected to be partially offset by strong proxy activity, part of which is driven by the new Pay Versus Performance disclosure. With that, I'll pass it back to Dan.